3D Printing human tissue: where biotechnology meets engineering

Abstract

Every day countless people are suffering and dying from several diseases. One of the reasons is because life-saving drugs often fail to get to market. In fact, 90% of new drugs that show promise in the lab or on animals, but, unfortunately, fail in humans and never end up making it to your pharmacy. Sometimes these drug failures are tragic, in one case, in the UK a drug company ―TeGenero Immuno Therapeutics‖ came upon a novel treatment for the devastating diseases, such as leukemia, rheumatoid arthritis and multiple sclerosis.